Form 4 for XFOR X4 Pharmaceuticals, Inc
Accepted 2022-02-14 00:00:00 ET · period of report 2022-02-11 · accession 0001628280-22-002507 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-14 | 2022-02-11 | XFOR | Taveras Arthur | CSO | F - Tax | $0.00 | -928 | 7,107 | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-11 | F | D | 928 | $0.00 | 7,107 | D | — | — | (F2) Shares withheld by X4 Pharmaceuticals Inc. to satisfy taxes payable in connection with the vesting of previously awarded restricted stock units. (F3) Of the shares of common stock reported, 5,357 shares represent unvested restricted stock units. |